Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Motor Neuron Disease, Amyotrophic Lateral Sclerosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT02193893
What this trial is testing

Biological Treatment of Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Pomeranian Medical University Szczecin 50
Not applicableLooking for participantsNCT06765564
What this trial is testing

Clinical Study of Induced Pluripotent Stem Cells Derived Motor Neuron Precursor Cell Therapy for Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
ALS
Shanghai East Hospital 3
Not applicableActive Not RecruitingNCT03912987
What this trial is testing

TRIAL READY (Clinical Trial Readiness)

Who this might be right for
Amyotrophic Lateral SclerosisFrontotemporal DementiaALS-Frontotemporal Dementia+2 more
University of Miami 610
Not applicableLooking for participantsNCT01772602
What this trial is testing

The National Amyotrophic Lateral Sclerosis Registry

Who this might be right for
Amyotrophic Lateral Sclerosis
Centers for Disease Control and Prevention 30,000
Testing effectiveness (Phase 2)Study completedNCT00647296
What this trial is testing

Safety and Tolerability Study of KNS-760704 in Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Knopp Biosciences 194
Not applicableStudy completedNCT02686268
What this trial is testing

Understanding Clinical Phenotype and Collecting Biomarker Samples in C9ORF72 ALS

Who this might be right for
C9ORF72 Amyotrophic Lateral Sclerosis (ALS)
Washington University School of Medicine 128
Large-scale testing (Phase 3)UnknownNCT03690791
What this trial is testing

Efficacy of Cannabinoids in Amyotrophic Lateral Sclerosis or Motor Neurone Disease

Who this might be right for
Amyotrophic Lateral SclerosisMotor Neuron Disease
Gold Coast Hospital and Health Service 17
Large-scale testing (Phase 3)Study completedNCT00136110
What this trial is testing

Trial of Sodium Valproate in Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
UMC Utrecht 165
Not applicableStudy completedNCT04939818
What this trial is testing

Clinical Feasibility of Speech Phenotyping for Remote Assessment of Neurodegenerative and Psychiatric Disorders

Who this might be right for
Alzheimer DiseaseMild Cognitive ImpairmentDementia With Lewy Bodies+8 more
Novoic Limited 172
Early research (Phase 1)Study completedNCT05974579
What this trial is testing

Safety and Dosimetry of a New Radiotracer to Detect Misfolded SOD1 Associated With Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Université de Sherbrooke 8
Post-approval studies (Phase 4)Study completedNCT06849115
What this trial is testing

Effects of L-Carnitine in Amyotrophic Lateral Sclerosis Patients With CHCHD10 Mutations

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
ChaodongWang 4
Not applicableLooking for participantsNCT07467187
What this trial is testing

Invasive Home Ventilation in Denmark

Who this might be right for
Neuromuscular Diseases (NMD)ALS (Amyotrophic Lateral Sclerosis)Spinal Cord Injuries (SCI)+5 more
Rigshospitalet, Denmark 450
Not applicableLooking for participantsNCT07268833
What this trial is testing

Translating Single-cell Vulnerability Into Novel ALS Biomarkers and Therapeutic Targets: Towards a Liquid Nerve Biopsy

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)Peripheral Neuropathies
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta 400
Testing effectiveness (Phase 2)Looking for participantsNCT07660614
What this trial is testing

LTX-002 in Adult Participants With Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Leal Therapeutics, Inc 56
Not applicableStudy completedNCT00015444
What this trial is testing

Screening and Natural History: Primary Lateral Sclerosis and Related Disorders

Who this might be right for
Primary Lateral Sclerosis
National Institute of Neurological Disorders and Stroke (NINDS) 189
Testing effectiveness (Phase 2)Study completedNCT02238626
What this trial is testing

Ibudilast (MN-166) in Subjects With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
MediciNova 70
Large-scale testing (Phase 3)Study completedNCT00415519
What this trial is testing

Efficacy and Safety Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis (ALS) Who Met Severity Classification III

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
Shionogi 25
Not applicableStudy completedNCT03085706
What this trial is testing

Transplantation of Autologous Peripheral Blood Mononuclear Cells for Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
The First Affiliated Hospital of Dalian Medical University 14
Not applicableStudy completedNCT02104921
What this trial is testing

Innovative Ultrasound Technology in Neuromuscular Disease

Who this might be right for
Amyotrophic Lateral SclerosisMuscular DystrophyRadiculopathy+4 more
Beth Israel Deaconess Medical Center 223
Early research (Phase 1)Study completedNCT01640067
What this trial is testing

Human Neural Stem Cell Transplantation in Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Azienda Ospedaliera Santa Maria, Terni, Italy 18
Next Page